Timpani Capital Management’s Evolent Health EVH Stock Holding History

Timpani Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-188,751	Closed	-$4.79M	–	108
2017 Q2	$4.79M	Buy	188,751 +27,812	+17%	+$669K	1.78%	11
2017 Q1	$3.59M	Buy	160,939 +115,895	+257%	+$2.22M	1.44%	26
2016 Q4	$667K	Buy	45,044 +9,109	+25%	+$179K	0.28%	95
2016 Q3	$885K	Buy	+35,935	New	+$840K	0.35%	79

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Timpani Capital Management's EVH Position: Q3 2017 in Review

Timpani Capital Management sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 188,751 shares — an estimated $4.79M sold.

Timpani Capital Management first reported a position in EVH in Q3 2016 and held it in 4 quarters. The position peaked at $4.79M in Q2 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

Timpani Capital Management reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
Timpani Capital Management sold 188,751 Evolent Health shares in Q3 2017, an estimated $4.79M.
Timpani Capital Management first reported a position in Evolent Health in Q3 2016 and held it in 4 quarters.
Timpani Capital Management's Evolent Health position peaked at $4.79M in Q2 2017.
166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on Timpani Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.